MedTrace Logo

A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes

NCT03571724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2020-09-16

Study results available
· View outcomes & findings →

Summary

This study evaluates the impact of switching from usual brand cigarettes to very low nicotine cigarettes on cigarette consumption, smoking behavior, and biomarkers of exposure.

Conditions

  • Tobacco Use

Interventions

OTHER

Non-Menthol Very Low Nicotine Cigarettes

King size non-menthol cigarettes containing 0.4mg nicotine /g tobacco

OTHER

Menthol Very Low Nicotine Cigarettes

King size menthol cigarettes containing 0.4mg nicotine /g tobacco

OTHER

Subject's UB non-mentholated filtered cigarettes

King size non-menthol cigarettes

OTHER

Subject's UB mentholated filtered cigarettes

King size menthol cigarettes

Sponsors & Collaborators

  • Celerion

    collaborator INDUSTRY

  • 22nd Century Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip L Matthew, MD · Celerion

  • Melanie Fein · High Point Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
26 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-28
Primary Completion
2019-01-25
Completion
2019-03-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571724 on ClinicalTrials.gov